West Nile Virus (WNV) is a mosquito-borne pathogen of global significance. It is active on several continents and is responsible for recent outbreaks of fever and fatal encephalitis in humans and horses. While highly virulent strains have been reported in Europe, North, Central and South America, only a benign subtype of WNV (Kunjin virus – KUNV) occurs in Australia. However, virulent, exotic WNV strains are seen as a significant threat to Australia due to the ease with which this virus can move between continents and the presence of suitable vectors and hosts already within Australia. KUNV and WNV subtypes are antigenically and genetically very closely related and cross-react in traditional serological tests. This cross-reactivity makes it very difficult to differentiate between KUNV and WNV infections using standard serological tests. The aim of this thesis was to identify immunogenic epitopes unique to KUNV or WNV and to use these epitopes in the development of a rapid assay that would enable the diagnosis of and surveillance for exotic virulent strains of WNV in Australia. The rapid diagnostic platform chosen was a red blood cell (RBC) agglutination assay that was originally patented and commercialised by AGEN Biomedical Ltd. The RBC agglutination assay reagent consists of the Fab region of a human erythrocyte-specific monoclonal antibody (mAb) conjugated to the epitope of interest (in this instance, a WNV-specific peptide). This bi-functional reagent causes the agglutination of the patient’s erythrocytes in the presence of WNV-specific antibody in the patient’s serum. Traditionally, these RBC agglutination reagents have been produced by chemical conjugation. However, a potentially easier and cheaper method involves the linking of the gene encoding the erythrocyte-specific antibody to that encoding the epitope to create a recombinant version of the bi-functional agglutination reagent through expression using prokaryotic or eukaryotic systems. To identify potential differential epitopes, 18 mAbs to WNV (NY99 strain) prM and envelope (E) proteins were assessed. One mAb (17D7) differentially recognised WNV and KUNV in ELISA and maintained recognition of its corresponding epitope upon reduction and carboxymethylation of the viral antigen, suggesting a continuous (linear) epitope. Using synthetic peptides, the epitope was mapped to a 19 amino acid sequence (WN19: E147-165) encompassing the WNV NY99 E protein glycosylation site at position 154. An amino acid substitution at position E156 of many KUNV strains abolishes this glycosylation moiety. The inability of WNV-positive horse and mouse sera to bind the synthetic peptides indicated that glycosylation was required for recognition of peptide WN19 by WNV-specific antibodies in sera. N-linked glycosylation of WN19 was achieved through expression of the peptide as a C-terminal fusion protein in mammalian cells and specific reactivity of WNV-positive horse sera to the glycosylated WN19 fusion protein was shown by Western blot. Additional sera collected from horses that had been infected with Murray Valley encephalitis virus (MVEV), which is similarly glycosylated at position E154 and exhibits high sequence identity to WNV NY99 in this region, also recognised the recombinant peptide. In contrast, no reactivity with the recombinant peptide was observed by sera from horses infected with the unglycosylated WNV subtype, KUNV. Failure of most WNV- and MVEV-positive horse sera to recognise the epitope as a deglycosylated fusion protein (75% and 100% respectively) confirmed that the N-linked glycan is important for antibody recognition of the peptide. Together, these results suggest that the induction of antibodies to the WN19 epitope during WNV infection of horses is generally associated with E protein glycosylation of the infecting viral strain. To assess the feasibility of using peptide WN19 in a rapid immunoassay, the peptide was recombinantly fused to a RBC (glycophorin)-specific single chain antibody (scFv) using previously published constructs which were developed for the bacterial expression of similar bi-functional reagents. To facilitate glycosylation of peptide WN19, the genes for the bi-functional agglutination reagents were subsequently cloned into eukaryotic expression vectors. An additional set of constructs were also produced in which the genes for the variable regions of the anti-RBC antibody were cloned into a vector for the secreted expression of an intact, humanised IgG1 molecule. Stable cell lines were produced for each of these constructs and secreted up to 700 ng/mL glycophorin-reactive antibody. The secreted recombinant protein could be harvested directly from the cell culture medium and used in RBC agglutination assays, where these bi-functional agglutination reagents could be cross-linked either with mAb 17D7 or by anti-peptide WN19 antibodies present in WNV-positive horse serum. The WNV NY99 prM protein was also identified as a useful marker of WNV-infection in horses, as well as a putative antigen to differentiate equine WNV NY99 and KUNV infections using Western blot. Two anti-WNV prM mAbs were also generated in this study and will be extremely valuable in future studies. Preliminary analysis of the prM epitope(s) bound by these mAbs and WNV-immune sera indicate that the binding site(s) is likely to be localised to pr and is conformational.

West Nile Virus (WNV) is a mosquito-borne pathogen of global significance. It is active on several continents and is responsible for recent outbreaks of fever and fatal encephalitis in humans and horses. While highly virulent strains have been reported in Europe, North, Central and South America, only a benign subtype of WNV (Kunjin virus – KUNV) occurs in Australia. However, virulent, exotic WNV strains are seen as a significant threat to Australia due to the ease with which this virus can move between continents and the presence of suitable vectors and hosts already within Australia. KUNV and WNV subtypes are antigenically and genetically very closely related and cross-react in traditional serological tests. This cross-reactivity makes it very difficult to differentiate between KUNV and WNV infections using standard serological tests. The aim of this thesis was to identify immunogenic epitopes unique to KUNV or WNV and to use these epitopes in the development of a rapid assay that would enable the diagnosis of and surveillance for exotic virulent strains of WNV in Australia. The rapid diagnostic platform chosen was a red blood cell (RBC) agglutination assay that was originally patented and commercialised by AGEN Biomedical Ltd. The RBC agglutination assay reagent consists of the Fab region of a human erythrocyte-specific monoclonal antibody (mAb) conjugated to the epitope of interest (in this instance, a WNV-specific peptide). This bi-functional reagent causes the agglutination of the patient’s erythrocytes in the presence of WNV-specific antibody in the patient’s serum. Traditionally, these RBC agglutination reagents have been produced by chemical conjugation. However, a potentially easier and cheaper method involves the linking of the gene encoding the erythrocyte-specific antibody to that encoding the epitope to create a recombinant version of the bi-functional agglutination reagent through expression using prokaryotic or eukaryotic systems. To identify potential differential epitopes, 18 mAbs to WNV (NY99 strain) prM and envelope (E) proteins were assessed. One mAb (17D7) differentially recognised WNV and KUNV in ELISA and maintained recognition of its corresponding epitope upon reduction and carboxymethylation of the viral antigen, suggesting a continuous (linear) epitope. Using synthetic peptides, the epitope was mapped to a 19 amino acid sequence (WN19: E147-165) encompassing the WNV NY99 E protein glycosylation site at position 154. An amino acid substitution at position E156 of many KUNV strains abolishes this glycosylation moiety. The inability of WNV-positive horse and mouse sera to bind the synthetic peptides indicated that glycosylation was required for recognition of peptide WN19 by WNV-specific antibodies in sera. N-linked glycosylation of WN19 was achieved through expression of the peptide as a C-terminal fusion protein in mammalian cells and specific reactivity of WNV-positive horse sera to the glycosylated WN19 fusion protein was shown by Western blot. Additional sera collected from horses that had been infected with Murray Valley encephalitis virus (MVEV), which is similarly glycosylated at position E154 and exhibits high sequence identity to WNV NY99 in this region, also recognised the recombinant peptide. In contrast, no reactivity with the recombinant peptide was observed by sera from horses infected with the unglycosylated WNV subtype, KUNV. Failure of most WNV- and MVEV-positive horse sera to recognise the epitope as a deglycosylated fusion protein (75% and 100% respectively) confirmed that the N-linked glycan is important for antibody recognition of the peptide. Together, these results suggest that the induction of antibodies to the WN19 epitope during WNV infection of horses is generally associated with E protein glycosylation of the infecting viral strain. To assess the feasibility of using peptide WN19 in a rapid immunoassay, the peptide was recombinantly fused to a RBC (glycophorin)-specific single chain antibody (scFv) using previously published constructs which were developed for the bacterial expression of similar bi-functional reagents. To facilitate glycosylation of peptide WN19, the genes for the bi-functional agglutination reagents were subsequently cloned into eukaryotic expression vectors. An additional set of constructs were also produced in which the genes for the variable regions of the anti-RBC antibody were cloned into a vector for the secreted expression of an intact, humanised IgG1 molecule. Stable cell lines were produced for each of these constructs and secreted up to 700 ng/mL glycophorin-reactive antibody. The secreted recombinant protein could be harvested directly from the cell culture medium and used in RBC agglutination assays, where these bi-functional agglutination reagents could be cross-linked either with mAb 17D7 or by anti-peptide WN19 antibodies present in WNV-positive horse serum. The WNV NY99 prM protein was also identified as a useful marker of WNV-infection in horses, as well as a putative antigen to differentiate equine WNV NY99 and KUNV infections using Western blot. Two anti-WNV prM mAbs were also generated in this study and will be extremely valuable in future studies. Preliminary analysis of the prM epitope(s) bound by these mAbs and WNV-immune sera indicate that the binding site(s) is likely to be localised to pr and is conformational.

West Nile Virus (WNV) is a mosquito-borne pathogen of global significance. It is active on several continents and is responsible for recent outbreaks of fever and fatal encephalitis in humans and horses. While highly virulent strains have been reported in Europe, North, Central and South America, only a benign subtype of WNV (Kunjin virus – KUNV) occurs in Australia. However, virulent, exotic WNV strains are seen as a significant threat to Australia due to the ease with which this virus can move between continents and the presence of suitable vectors and hosts already within Australia. KUNV and WNV subtypes are antigenically and genetically very closely related and cross-react in traditional serological tests. This cross-reactivity makes it very difficult to differentiate between KUNV and WNV infections using standard serological tests. The aim of this thesis was to identify immunogenic epitopes unique to KUNV or WNV and to use these epitopes in the development of a rapid assay that would enable the diagnosis of and surveillance for exotic virulent strains of WNV in Australia. The rapid diagnostic platform chosen was a red blood cell (RBC) agglutination assay that was originally patented and commercialised by AGEN Biomedical Ltd. The RBC agglutination assay reagent consists of the Fab region of a human erythrocyte-specific monoclonal antibody (mAb) conjugated to the epitope of interest (in this instance, a WNV-specific peptide). This bi-functional reagent causes the agglutination of the patient’s erythrocytes in the presence of WNV-specific antibody in the patient’s serum. Traditionally, these RBC agglutination reagents have been produced by chemical conjugation. However, a potentially easier and cheaper method involves the linking of the gene encoding the erythrocyte-specific antibody to that encoding the epitope to create a recombinant version of the bi-functional agglutination reagent through expression using prokaryotic or eukaryotic systems. To identify potential differential epitopes, 18 mAbs to WNV (NY99 strain) prM and envelope (E) proteins were assessed. One mAb (17D7) differentially recognised WNV and KUNV in ELISA and maintained recognition of its corresponding epitope upon reduction and carboxymethylation of the viral antigen, suggesting a continuous (linear) epitope. Using synthetic peptides, the epitope was mapped to a 19 amino acid sequence (WN19: E147-165) encompassing the WNV NY99 E protein glycosylation site at position 154. An amino acid substitution at position E156 of many KUNV strains abolishes this glycosylation moiety. The inability of WNV-positive horse and mouse sera to bind the synthetic peptides indicated that glycosylation was required for recognition of peptide WN19 by WNV-specific antibodies in sera. N-linked glycosylation of WN19 was achieved through expression of the peptide as a C-terminal fusion protein in mammalian cells and specific reactivity of WNV-positive horse sera to the glycosylated WN19 fusion protein was shown by Western blot. Additional sera collected from horses that had been infected with Murray Valley encephalitis virus (MVEV), which is similarly glycosylated at position E154 and exhibits high sequence identity to WNV NY99 in this region, also recognised the recombinant peptide. In contrast, no reactivity with the recombinant peptide was observed by sera from horses infected with the unglycosylated WNV subtype, KUNV. Failure of most WNV- and MVEV-positive horse sera to recognise the epitope as a deglycosylated fusion protein (75% and 100% respectively) confirmed that the N-linked glycan is important for antibody recognition of the peptide. Together, these results suggest that the induction of antibodies to the WN19 epitope during WNV infection of horses is generally associated with E protein glycosylation of the infecting viral strain. To assess the feasibility of using peptide WN19 in a rapid immunoassay, the peptide was recombinantly fused to a RBC (glycophorin)-specific single chain antibody (scFv) using previously published constructs which were developed for the bacterial expression of similar bi-functional reagents. To facilitate glycosylation of peptide WN19, the genes for the bi-functional agglutination reagents were subsequently cloned into eukaryotic expression vectors. An additional set of constructs were also produced in which the genes for the variable regions of the anti-RBC antibody were cloned into a vector for the secreted expression of an intact, humanised IgG1 molecule. Stable cell lines were produced for each of these constructs and secreted up to 700 ng/mL glycophorin-reactive antibody. The secreted recombinant protein could be harvested directly from the cell culture medium and used in RBC agglutination assays, where these bi-functional agglutination reagents could be cross-linked either with mAb 17D7 or by anti-peptide WN19 antibodies present in WNV-positive horse serum. The WNV NY99 prM protein was also identified as a useful marker of WNV-infection in horses, as well as a putative antigen to differentiate equine WNV NY99 and KUNV infections using Western blot. Two anti-WNV prM mAbs were also generated in this study and will be extremely valuable in future studies. Preliminary analysis of the prM epitope(s) bound by these mAbs and WNV-immune sera indicate that the binding site(s) is likely to be localised to pr and is conformational.

abstract: Alzheimer's disease (AD) is the most common form of dementia leading to cognitive dysfunction and memory loss as well as emotional and behavioral disorders. It is the 6th leading cause of death in United States, and the only one among top 10 death causes that cannot be prevented, cured or slowed. An estimated 5.4 million Americans live with AD, and this number is expected to triple by year 2050 as the baby boomers age. The cost of care for AD in the US is about $200 billion each year. Unfortunately, in addition to the lack of an effective treatment or AD, there is also a lack of an effective diagnosis, particularly an early diagnosis which would enable treatment to begin before significant neuronal damage has occurred. Increasing evidence implicates soluble oligomeric forms of beta-amyloid and tau in the onset and progression of AD. While many studies have focused on beta-amyloid, soluble oligomeric tau species may also play an important role in AD pathogenesis. Antibodies that selectively identify and target specific oligomeric tau variants would be valuable tools for both diagnostic and therapeutic applications and also to study the etiology of AD and other neurodegenerative diseases. Recombinant human tau (rhTau) in monomeric, dimeric, trimeric and fibrillar forms were synthesized and purified to perform LDH assay on human neuroblastoma cells, so that trimeric but not monomeric or dimeric rhTau was identified as extracellularly neurotoxic to neuronal cells. A novel biopanning protocol was designed based on phage display technique and atomic force microscopy (AFM), and used to isolate single chain antibody variable domain fragments (scFvs) that selectively recognize the toxic tau oligomers. These scFvs selectively bind tau variants in brain tissue of human AD patients and AD-related tau transgenic rodent models and have potential value as early diagnostic biomarkers for AD and as potential therapeutics to selectively target toxic tau aggregates. / Dissertation/Thesis / Doctoral Dissertation Chemical Engineering 2014

No description available.

Comme je suis particulièrement intéressé par les nanosciences et les nombreuses applications des nanotechnologies, je me suis penché sur le développement de méthodes de fabrication de nanoparticules ultra-petites dont les fonctions peuvent être ajustées avec précision. Récemment, une nouvelle technologie appelée « technologie d’une seule chaîne », c’est-à-dire qui utilise une seule chaîne polymère, est devenue un sujet de recherche de plus en plus motivant pour la communauté scientifique. Cette technologie a l’avantage de dépendre d’une méthode facile de préparation de nanoparticules polymères d’une seule chaîne (SCNPs) et ayant des dimensions typiques de 1,5 à 20 nm. Leurs tailles ultra petites leur confèrent des propriétés spécifiques, ce qui permet de les utiliser comme capteurs, systèmes catalytiques, revêtements à faible viscosité, nanoréacteurs ou pour des applications biomédicales. Grâce aux contributions de nombreux scientifiques durant la dernière décennie, les méthodes de synthèse des SCNPs sont devenues très variées et représentent une technologie désormais mature. Néanmoins, de nombreux problèmes sont à résoudre dans ce domaine, ce qui permettra d’ajouter de nouvelles fonctions ou de les valoriser pour de nouvelles applications. Les polymères sensibles à plusieurs stimuli sont une classe de matériaux intelligents dont les propriétés peuvent être modifiées par l’application d’un stimulus extérieur. Ils sont utilisés extensivement dans les domaines énergétique et biomédical. Comme leurs propriétés physiques et chimiques peuvent être modifiées aisément et efficacement par un contrôle de leur environnement externe, ces polymères sont des candidats pour fabriquer de nouvelles SCNPs. Dans cette thèse, nous nous sommes intéressés au développement de SCNPs ayant de multiples fonctionnalités car cela permet d’ouvrir la voie pour de nouvelles applications. Pour cela, de nombreux polymères sensibles à plusieurs stimuli ont été préparés comme précurseurs à des SCNPs. En concevant spécifiquement ces polymères, il fut possible d’ajouter leurs propriétés de réponse à des stimuli dans les systèmes SCNPs. Le cœur même de cette thèse consiste en trois projets qui utilisèrent trois classes de SCNPs provenant de polymères sensibles aux stimuli. Grâce à leur réponse à plusieurs stimuli, ces SCNPs remplirent de nombreuses fonctions et subirent des modifications soit de leur structure, soit de leur morphologie, soit de leurs propriétés. Et en plus de la variété de fonctions, chaque classe de SCNPs a le potentiel pour de nombreuses applications. Dans la première étude présentée dans cette thèse (chapitre 1), nous avons préparé une classe de SCNPs photodégradables ayant une taille ajustable et inférieure à 10 nm. Il s’agit de polyesters rendus photosensibles par la présence de coumarines à l’intérieur de la chaîne principale (nommés CAPPG) grâce à la copolymérisation de coumarine diol, d’acide adipique et de propylène glycol (PPG). Cette incorporation de coumarines dans la chaîne principale permet au polymère d’être photosensible par deux façons. En effet, les coumarines peuvent se photo-dimériser, lorsqu’elles sont irradiées par des rayonnements UV (> 320 nm) en des cyclobutanes qui peuvent être ouverts à nouveau par d’autres rayonnements UV (254 nm) permettant la restauration des coumarines initiales. Cela a permis la création de SCNPs de tailles inférieures à 10 nm et incluant des propriétés de photodégradation. Cette propriété a été démontrée par une irradiation de 3 h avec des chaînes polymères de 13220 g/mol à 1385 g/mol dans les SCNPs. La taille de ces SNCPs (caractérisée par leur rayon hydrodynamique) peut être modifiée entre 3 nm et 5,3 nm en modifiant le taux de dimérisation des coumarines, ce qui est aisément obtenu en ajustant le temps d’irradiation UV. Les résultats ont démontré que cette méthode permet un contrôle aisé de la taille des SCNPs sans avoir recours à la synthèse de nombreux polymères précurseurs. Finalement, comme le polyester était biodégradable et biocompatible, ces SCNPs peuvent être exploitées pour des applications biomédicales. Dans la deuxième étude effectuée au cours de cette thèse (chapitre 2), nous avons préparé un nouveau type de SCNPs multifonctionnel à partir d’un polymère cristallin liquide. Il s’agit du polyméthacrylate de [2- (7-méthylcoumaryl) oxyéthyle - co - 6-[4-(4’-méthoxyphenylazo) phénoxy] hexyle] (PAzoMACMA). Les groupements latéraux du polymère contiennent, en majorité, des azobenzènes photoisomérisables et, en minorité, des coumarines photodimérisables. Les azobenzènes servent de mésogènes pour la formation de cristaux liquides alors que les coumarines ont été utilisées pour une réticulation photoinduite et intrachaîne. Malgré les dimensions inférieures à 15 nm, le confinement et la réticulation, les phases cristallines liquides (LC) persistèrent même dans les SCNPs. Ces SCNPs cristaux liquides (LC-SCNPs) présentèrent un certain nombre de propriétés intéressantes et particulières. Alors que leurs dispersions dans le THF n’étaient pas fluorescentes, celles dans le chloroforme l’étaient. En plus, ces nanoparticules s’aggloméraient quelque peu dans le chloroforme ce qui induisait des fluorescences différentes entre des SCNPs riches en isomères cis ou riches en isomères trans des azobenzènes. A cause de la photoisomérisation des azobenzènes, ces LC-SCNPs se déformaient sous irradiation comme le font les microparticules ou les colloïdes contenant des azobenzènes. Cependant, la déformation de ces nanoparticules dépend de la longueur d’onde de lumière polarisée. Alors que sous irradiation UV polarisée à 365 nm, l’élongation des SCNPs était perpendiculaire à la polarisation de la lumière incidente, sous irradiation visible polarisée entre 400 et 500 nm, l’étirement se faisait parallèlement à la polarisation. Finalement, un nanocomposite fut préparé par dispersion de LC-SCNPs dans une matrice de polyméthacrylate de méthyle (PMMA). Si celui-ci était étiré mécaniquement, les azobenzènes s’orientaient dans la direction de la déformation induite. Ces propriétés intéressantes des LC-SCNPs que cette étude a permis de dévoiler, suggèrent de nouvelles applications potentielles. Dans la troisième étude de cette thèse (chapitre 3), nous avons préparé une classe de SCNPs sensibles à la présence de CO2 et leurs agrégats micellaires auto-assemblés. D’un côté, des SCNPs ont été préparées à partir d’un polyméthacrylate de {(N, N-diméthylaminoéthyle)-co-4-méthyl-[7-(méthacryloyl)-oxyéthyl-oxy] coumaryle} (PDMAEMA-co-CMA). Lorsqu’elles sont dispersées en solution aqueuse, les nanoparticules individuelles peuvent subir des cycles réversibles d’expansion et de rétrécissement sous une stimulation alternative de CO2 et de N2 qui vont protoner et déprotoner les amines tertiaires. D’un autre côté, des SCNPs de type ‘Janus’ (SCJNPs) ont été préparées à partir d’un copolymère dibloc amphiphile : PS-b-P(DMAEMA-co-CMA) (PS correspond au polystyrène qui est hydrophobe). Ce type de SCJNPs peut s’autoassembler sous forme de micelles en solution aqueuse. Sous stimulation CO2 ou N2, l’expansion ou le rétrécissement à l’intérieur des particules permet de grands changements de volume. En plus, ces particules ont été étudiées comme potentiels nanoréacteurs pour des nanoparticules d’or (AuNPs) que ce soit sous formes SCNPs ou micelles SCJNPs. La vitesse de formation des AuNPs augmente sous bullage de CO2 et décroît sous N2. Cela permet de rendre possible cette réaction contrôlable par ces deux gaz. Qui plus est, utiliser des micelles de SCJNPs dont le volume peut être modifié sur un large intervalle en changeant l’intensité de la stimulation de CO2, permit d’obtenir des AuNPs de taille variable. / Abstract : With interests on nanoscience and nanotechnology for many applications, there is a demand for development of fabrication technology of ultra-small nano-size objects that allow for precise size control and tailored functionality. Recently, a new technology called ‘single-chain technology’, which manipulates a single polymer chain, becomes a rapidly-growing research topic. This technology provides a facile method to prepare polymer single-chain nanoparticles (SCNPs) with a typical size of 1.5-20 nm. Due to the ultra-small size-enabled unique properties, SCNPs have wide range of applications, including sensor, catalytic system, low viscosity coating, nanoreactor and biomedical applications. Through the contributions by many scientists in the past decade, the synthetic methodologies to fabricate SCNPs have been reported using various chemistries and been getting mature. However, there are still several unsolved problems in the field of SCNPs including functions and application. Stimuli-responsive polymers, as a class of smart materials whose properties can be changed by responding to external stimuli, have been widely used in energy and biomedical applications. Since their chemical and physical properties can be changed easily and efficiently via environmental control, stimuli-responsive polymers provide a potential pathway to preparing functional SCNPs. In this thesis, we are focusing on developing functional SCNPs, especially systems with multi-functions, and expanding their applications. To achieve this target, various stimuli-responsive polymers were prepared as polymer precursors and their stimuli-responsive properties were introduced into the SCNP systems by rational design of their chemical structures. The core of this thesis is comprised of three projects which deal with three classes of SCNPs from stimuli-responsive polymers. These stimuli-responsive SCNPs perform multi-functions and undergo certain change either in structure or morphology and properties. In addition, according to their variety of functions, each class of multi-functional SCNPs has diverse potential applications. In the first study presented in the thesis (Chapter 1), we prepared a class of sub-10 nm photodegradable and size-tunable SCNPs based on photo-responsive main-chain coumarin-based polyesters Poly{[7-(hydroxypropoxy)-4-(hydroxymethyl)coumarin adipate]-co- (polypropylene glycol adipate)} (CAPPG) through copolymerization of coumarin diol, adipic acid and polypropylene glycol (PPG). By incorporating coumarin moieties into the chain backbone of a polyester, dual photo-responsive reaction, i.e. photo-dimerization (>320 nm) and photo-induced chain scission (254 nm), occur under two different wavelengths of UV irradiation, enabling the preparation of sub-10 nm SCNPs and their photo-degradation property. The photo-degradability of SCNPs is evidenced under 254 nm UV irradiation for 3 h, which molecular weight of SCNPs decreasing from 13220 g/mol to 1385 g/mol. Moreover, the size of SCNPs can be tunable from 5.3 nm to 3 nm (hydrodynamic diameter) by varying the dimerization degree of coumarin moieties, that is simply controlled by the UV irradiation time. These results demonstrate a facile method to control the size of SCNPs without the need for synthesizing different polymer precursors. Finally, due to the biocompatible and biodegradable nature of polyester as polymer precursor, the SCNPs with photo-degradability and size-tunability have the potential to be exploited for biomedical applications. In the second study realized in this thesis (Chapter 2), we prepared a new type of multi-functional SCNPs from a side-chain liquid crystalline polymer (SCLCP), namely poly{6-[4-(4-methoxyphenylazo) phenoxy]hexylmethacrylate-co-4-methyl-[7-(methacr-yloyl) oxy-ethyl-oxy]coumarin} (PAzoMACMA). The polymer’s side groups comprise photo-isomerizable azobenzene in majority and photo-dimerizable coumarin in minority, with the former as mesogens and the latter for intra-chain photo-crosslinking. Despite the sub-15 nm size, confinement and crosslinking, the liquid crystalline (LC) phases of bulk PAzoMACMA persist in SCLCPs. Such LC-SCNPs exhibit a number of interesting and peculiar properties. While their dispersion in THF is non-fluorescent, when dispersed in chloroform, the nanoparticles appear to agglomerate to certain degree and display significant fluorescence that is different for SCNPs rich in the trans or cis isomer of azobenzene. The azobenzene LC-SCNPs also undergo photo-induced deformation, similar to azobenzene micro- or colloidal particles. However, the elongational deformation of the nanoparticles is dependent upon the linearly polarized excitation wavelength. While under polarized 365 nm UV irradiation the SCNP stretching direction is perpendicular to the light polarization, under polarized 400-500 nm visible light irradiation, the stretching takes place along the light polarization direction. Finally, an all-polymer nanocomposite was prepared by dispersing the LC-SCNPs in poly(methyl methacrylate) (PMMA), and mechanically stretching-induced orientation of azobenzene mesogens developed along the strain direction. The interesting properties of LC-SCNPs unveiled in this study suggest new possibilities for applications including bio-imaging and LC materials. As the third study in this thesis (Chapter 3), we studied a class of CO2-responsive SCNPs and their self-assembled micellar aggregates. On one hand, SCNPs are prepared from a random copolymer of poly{(N,N-dimethylaminoethyl methacrylate)-co-4-methyl-[7-(methacryloyl)oxyethyl-oxy]coumarin} (P(DMAEMA-co-CMA)). When dispersed in aqueous solution, individual nanoparticles can undergo reversible swelling/shrinking under alternating CO2/N2 stimulation as a result of the reversible protonation/deprotonation of tertiary amine groups. On the other hand, tadpole-like single-chain ‘Janus’ nanoparticles (SCJNPs) are prepared using an amphiphilic diblock copolymer of PS-b-P(DMAEMA-co-CMA) (PS is hydrophobic polystyrene). This type of SCJNPs can self-assemble into core-shell micellar aggregates in aqueous solution. Under CO2/N2 stimulation, the collective swelling/shrinking of SCJNPs within the micelle results in large, reversible volume change. In addition, both P(DMAEMA-co-CMA) SCNPs and PS-b-P(DMAEMA-co-CMA) SCJNP micelles are explored as gas-tunable nanoreactors for gold nanoparticles (AuNPs). The rate of AuNP formation increases under CO2 stimulation and decreases upon N2 bubbling, which makes it possible to tune the reaction rate up and down (on/off switching) by using the two gases. Moreover, using the micelles of SCJNPs, whose volume can be controlled over a wide range by adjusting the CO2 stimulation strength, variable-size AuNPs and their aggregates are obtained with continuous redshift of the surface plasmon resonance (SPR) into the long wavelength visible light region.

Contraception through a vaccine has been a very attractive proposition and several attempts were made in the past. To achieve contraception through immunological means, several points need to be considered. First, the targeted antigen should be an important component of reproduction and interference in its actions should lead to infertility. Second, the antigen must be highly immunogenic and the antibodies elicited should be able to block the functions of the antigen. Third, the antibody titres should be effective and must sustain for longer periods. Gonadotropins fulfill all the above criteria and therefore, have been attractive targets for developing human contraceptive vaccines. The pituitary gonadotropins- Luteinizing hormone (LH) and the Follicle stimulating hormone (FSH) are the principal regulators of the reproduction process in all the mammalian species (McLachlan et al., 1995c; Moudgal et al., 1992b; Murty et al., 1979a; Selvaraj and Moudgal, 1994a; Weinbauer et al., 1991). In males, LH binds to its specific receptor-LHR, expressed on the Leydig cells and regulates the production of testosterone. This testosterone binds to the androgen receptors expressed in the Sertoli cells and along with FSH, which binds to the specific receptors present on the Sertoli cell membranes, regulate the testicular functions and the spermatogenesis (Simoni et al., 1997; Themmen and Huhtaniemi, 2000; Ulloa-Aguirre and Timossi, 1998). The well documented studies have unequivocally established that the specific immunoneutralization of either hormone by active or passive immunization, leads to disruption of the gonadal functions (Fraser et al., 1986a; Marathe et al., 1995; Moudgal et al., 1992b; Murty et al., 1979b; Shetty et al., 1996; Srinath et al., 1983b) and consequent infertility and this observation formed the basis of the human contraceptive vaccines (Moudgal et al., 1997b; Talwar et al., 2011a; Talwar et al., 2009a). Several studies using testosterone as the main male hormonal contraception method (Matsumoto et al., 1986; Matsumoto et al., 1983a) and anti-hCG vaccine as the female hormonal contraceptive vaccine reached Phase I and II clinical trials (Talwar, 1997; Talwar et al., 1994; Talwar et al., 1997) . However, these human contraceptive vaccines faced several limitations. There was a need to inhibit only particular segments of the entire reproduction process whereas others needed to remain completely unaffected. For example, in males, the FSH regulated functions, the sperm production and spermatogenesis needed to be inhibited whereas the LH/testosterone associated functions should be unaffected. Similarly in females, the functions of hCG alone, elaborated by the conceptus should be blocked without affecting either LH or FSH regulated functions, thus, maintaining the normal reproductive cycle. This however is a difficult task especially when the antigens share a large degree of homology and common subunits (Pierce and Parsons, 1981). Moreover, the issues relating to the development and sustenance of high titres of the bioneutralizing antibodies were major limitations of these human contraceptive vaccines. Therefore, despite reaching Phase I and II clinical trials, these studies did not progress further. However, the same concept of an immunocontraceptive vaccine involving the neutralization of the functions of the gonadotropins is an extremely attractive strategy for controlling the animal populations where the reproduction process could be inhibited in its entirety. The overgrowing populations of the stray animals such as dogs and cats pose problems unlike those experienced with the human overpopulation. Thus, there is an immediate need to develop the methods of controlling the populations of these animals both in the developed and the developing countries. Whereas, in countries like the US, the major emphasis is on the domestic animals, in countries like India, the populations of the stray animals need to be controlled. The current methods employed for reducing the numbers of these animals include either castration or culling of the animals. These methods are however, traumatic, unsafe and not widely accepted by the society. The animal contraceptive vaccines currently available are mostly GnRH vaccines which have high cost of production, are not safe for animal use and elicit unwanted side effects. Apart from these, the animals need multiple administrations of these vaccines to elicit high and effective antibody titres, mostly with the use of conventional but non-approved adjuvants (Boedeker et al., 2009; McCoy, 1994). As mentioned above, the gonadotropins, by virtue of their ability to control the mammalian reproduction process, are attractive targets for achieving contraception. Moreover, the ease of administration of this vaccine to neutralize the functions of the endogenous circulating hormones makes them ideal targets for developing animal immunocontraceptive vaccines. This method of neutralizing the functions of the gonadotropins is also humane and safe for the animals as opposed to the current methods which are employed to reduce their numbers. However, in case of animal contraception, particularly for strays such as dogs, where large numbers of animals need to be treated, the challenge is to develop a method to sustain the high levels of the bioneutralizing antibodies for prolonged periods preferably with a single administration of the immunogen and without the use of conventional adjuvants such as the Freund’s adjuvant. In the present study, an attempt has been made develop a strategy to achieve a sustained immune response to small quantities of the hormonal antigens, preferably with a single administration of the immunogen resulting in complete disruption of the gonadal function for prolonged periods. To achieve this goal, recent developments in the field of immunology and vaccinology have been employed. This involves targeting of the hormonal antigens to the dendritic cells. Targeting the antigens to the dendritic cells for vaccination is becoming an extremely fascinating strategy and is being used extensively to target the antigens involved in several diseases (Escudier et al., 2005; Frankel et al., 1998; Garcia et al., 2005; Nouri-Shirazi et al., 2000a; Nouri-Shirazi et al., 2000b; Steinman and Germain, 1998). Most antigens are targeted to the dendritic cells by coupling them to the antibodies specific for the receptors expressed on the dendritic cell surface. One such receptor is the DEC205, which is expressed on most of the dendritic cells (Jiang et al., 1995) and is being widely used to develop vaccines and vaccination strategies. Targeting the antigens to the dendritic cells provides advantages such as ability to induce hundred fold higher immune response to very low doses of antigen without the use of any conventional adjuvant (Bonifaz et al., 2004a). Therefore, in the present study, these features of the dendritic cells have been harnessed to target the hormonal antigens (hCG and hFSH) to the canine DEC205 receptor to induce a long-term immune response capable of disrupting the gonadal functions. Towards this goal of delivering hormonal antigens to the dendritic cells, a fragment of the canine DEC205 corresponding to the Cysteine Rich Fibronectin II domain (CR/FNII) was expressed and used to isolate several canine DEC205 specific recombinant antibodies in the form of single chain fragment variable (ScFvs) from the Tomlinson’s and the yeast human ScFv display libraries. From a pool of eight unique ScFvs screened from the Tomlinson’s libraries, three ScFvs namely B3, G10 and H4 were characterized. All these ScFvs could bind to the human DEC205 receptor but not to the mouse DEC205. Their inability to recognise the mouse DEC205 suggested that mouse could not be used as the model system for these studies and therefore, a surrogate model system was needed. As the canine CR/FNII shared a high degree of homology with the rabbit counterpart, adult rabbits have been used as the surrogate model for immunization studies after confirming the binding of the ScFvs to the rabbit dendritic cells. Since the goal of the study was to deliver the hormonal antigens to the dendritic cells, each ScFv was translationally fused to a core streptavidin fragment, thus creating bi-functional agents (ScFv-CS) capable of binding to the dendritic cells and also to any biotin-tagged antigen, thus delivering the antigen to the dendritic cells. Of the three ScFvs, the ScFv-CS-H4 which could bind to the canine CR/FNII with the KD of 25nM was used for demonstrating the ability of the ScFv-hormone complex to elicit the bioneutralizing antibody response. The ScFv-CS-H4-biotin-hCG or hFSH or both were administered to adult male rabbits along with poly IC: LC, a Toll-like receptor agonist and the antibody titres were monitored. It was possible to maintain high titres of the bioneutralizing antibodies for more than one year with a single administration of the immunogen. Testicular histology of the immunized animals showed extensive disruption of spermatogenesis with most of the germ cells being TUNEL positive undergoing apoptosis. There was complete absence of elongated spermatids and sperms in the testis indicating infertility caused by immunization with the gonadotropins. These data show that targeting the hormonal antigens to the dendritic cells leads to long-term infertility with minimal immunization. Although the ScFvs from the Tomlinson’s libraries were able to deliver the hormonal antigens to the dendritic cells and produce robust and sustained antibody response capable of disrupting the gonadal functions, the affinities of these ScFvs to DEC205 were moderate. It was felt that increasing the affinities of the ScFvs could enhance the effect with respect to the dose of the antigen that needs to be administered and the duration until which the high antibody titres could be maintained. Therefore, the yeast human ScFv display library offering higher diversity of the human ScFvs displayed, was screened for high affinity DEC205 specific binders. From a pool of several ScFvs, six unique ScFvs were characterized. The amino acid sequences of all ScFvs followed the Kabat's rules for identifying the complimentarity determining regions of the heavy and the light chains of the antibodies. All these ScFvs were unique in their amino acid sequences. The dissociation constants of all these antibodies for the canine CR/ FNII ranged from 10-9 to 10-11 M which was 20-300 fold higher than the ScFvs obtained from the Tomlinson’s libraries. The best ScFv obtained from this library was ScFv-92 with a KD value of 8 x10-11 M. All these ScFvs were able to deliver the payload antigen to both, the mouse DEC205 over-expressing cells and the bone marrow derived dendritic cells. Mice immunized with yeast display ScFvs also yielded antibody response to very small quantities of the immunogen with the highest antibody titres obtained with the ScFv-92. It was further demonstrated that all ScFvs also activated the cell-mediated immunity with significant increase in the antigen stimulated T cell proliferation. These ScFvs could also deliver the antigen to the human dendritic cells differentiated from the human monocytes in vitro, thus emphasising their utility in human vaccine development. An attempt was also made to develop nanoparticle (NP) based strategies of delivering the antigen to the dendritic cells. The PLGA-NPs, encapsulating hCG and coated with the DEC205 ScFv-92 was able to elicit high antibody response to very low doses of the antigen. This response could be sustained for 120 days and was higher than the response obtained with similar doses of hCG encapsulated NPs or hCG complexed to ScFv-92 alone. Targeting of the NPs also elicited antigen specific T cell response thus, potentiating their use in cell mediated immunity along with humoral immune responses. In conclusion, this approach of delivering the gonadotropins to the dendritic cells resulted in the production of bioneutralizing antibodies that could disrupt the gonadal functions for a prolonged period and can be effectively used in the fields for controlling the animal populations. This method fulfils all the criteria for any animal contraception. This strategy also elicits both T cell mediated and humoral immunity and can thus be used for producing vaccine against viral and parasitic infections. It can also be used for cancer immunotherapy. Another exciting feature of the strategy used in this study is the usage of ScFv-CS which allows the delivery of any biotin tagged antigen to the rodent and human dendritic cells. As discussed above, the methods for controlling the animal populations are expected to be effective, humane, safe, simple, non-surgical, single shot with long lasting effects, cheap, applicable in the fields and widely accepted by different societies. The methods presented in this study fulfill all these criteria and should be effective in controlling populations of different animal species.

Depuis leur découverte dans les années 90, les molécules-aimants constituent une classe de matériaux magnétiques qui a attiré l'attention du fait de leur bistabilité magnétique. Ces systèmes donnent l’espoir formidable de pouvoir stocker un bit d’information à l’échelle moléculaire. Ainsi, leur organisation dans des réseaux est devenue un enjeu essentiel en vue de leur intégration dans des dispositifs. Lors de cette thèse, l’organisation contrôlée de ces molécules par chimie de coordination en utilisant différents connecteurs s’est révélée être une stratégie de choix. Le chapitre I présente une approche théorique de ce projet de recherche. Dans ce chapitre, les propriétés de molécules-aimants, chaînes-aimants, conversion de spin et transfert d'électron sont décrits et discutés. Le chapitre II contient la bibliographie pertinente sur les réseaux de coordination à base de molécules-aimants et les systèmes photoactifs bimétalliques conténant des groupements cyanures. Le chapitre III présente l'organisation de molécules aimants[Mn4] en réseaux 1D et 2D par des liens diamagnétiques (ions chlorures) ou des liens paramagnétiques contenant des ions métalliques (NiII, MnII et CuII). Les études physiques (cristallographie par rayons X, mesuresmagnétiques et de chaleurs spécifiques) et des analyses théoriques sur ces nouveaux réseaux ont montré des propriétés magnétiques améliorées par rapport à la molécule-aimant [Mn4] isolée. Dans le chapitre IV, nous avonspréparé de nouveaux connecteurs commutables pour in fine concevoir des réseaux de molécules-aimants photomagnétiques. Une approche « building-block » a été utilisée pour obtenir un composé binucléaire de Fe et Co.Des études spectroscopiques, électrochimiques et magnétiques ont été effectuées et ont révélé sans ambiguïté une conversion de spin thermo-induite à l'état solide, et un transfert d'électron intramoléculaire assisté par protonation contrôlée en solution, accompagnés de changements optiques et magnétiques. Pour la première fois, ce nouveaucomplexe montre deux processus de commutation distincts selon son état physique et le stimulus externe utilisé. / The beginning of the 1990’s marked the discovery of Single-Molecule Magnets (SMMs), which created the hope tostore information on a single molecule due to their magnetic bistability. However, it is becoming of strategicimportance to dedicate a part of our research to their organization in order to achieve devices for the potentialapplication. During this thesis work, our strategy was to exploit coordination chemistry to organize these moleculesin a controlled way by using different types of linkers.Chapter I covers theoretical backgrounds for this research project. In this chapter, Single-Molecule Magnets(SMMs), Single-Chain Magnets (SCMs), Spin Crossover (SC) and Electron Transfer (ET) systems are described anddiscussed. Chapter II contains relevant literature on SMM-based coordination networks and photoactive cyanidobasedbimetallic systems. Chapter III presents the organization of [Mn4] SMMs in 1D and 2D networks withdiamagnetic linkers (chlorido ions) or paramagnetic linkers containing NiII, MnII, and CuII ions. The extensivephysical studies (X-ray crystallography, magnetic and heat capacity measurements, and theoretical analysis) on thesenetworks demonstrated new magnetic behavior and enhanced energy barrier compared to the isolated [Mn4] SMMs.In Chapter IV, we prepared new switchable linkers based on the cyanido-bridged Fe/Co unit, to realizephotomagnetic networks of SMMs. A rational building-block approach has been used to design these dinuclearFe/Co complexes. Extensive spectroscopic, electrochemical and magnetic characterizations have been performed tounambiguously reveal in one of the synthesized complexes the presence of a spin crossover induced by temperaturein the solid-state, and an intramolecular electron transfer assisted by controlled protonation in solution, bothaccompanied by optical and magnetic changes. For the first time, this new complex shows two distinct switchingprocesses depending on its physical state and external stimuli.

Dans cette thèse, nous avons synthétisé de nouveaux matériaux moléculaires hétérométalliques pontés par des groupements cyanures en utilisant la chimie de coordination donneur-accepteur. Les précurseurs moléculaires basés sur un ion métallique 3d (MnII/III, FeII, NiII, CuII) agissent en tant qu’unités acceptrices, alors que les précurseurs 4d (RuIII) et 5d (ReIV) de type trans-cyanido ont été utilisés comme groupements donneurs. Le chapitre I présente une approche théorique avec quelques exemples des matériaux magnétiques de basse dimensionnalité : molécule et chaîne aimant qui illustrent le rôle du ligand cyanido pour concevoir les matériaux magnétiques. En outre, nous avons sélectionné des précurseurs cyanido à base de métaux 4d/5d pour leur anisotropie magnétique plus élevée par rapport aux ions de métaux 3d. Le choix des précurseurs moléculaires, leur synthèse et leur caractérisation ont été largement décrits dans le chapitre II. Au cours de ce travail de recherche, nous avons obtenu de nombreux systèmes moléculaires hétérométalliques mais également des systèmes unidimensionnels. Les chapitres III, IV et V décrivent la synthèse, la structure cristallographique et la caractérisation magnétique de tous les complexes synthétisés. L’empilement cristallin compact des molécules conduit à un état fondamental antiferromagnétique pour la plupart des complexes ce qui perturbe souvent les phénomènes de relaxation magnétique. Nous avons donc établi les diagrammes de phases magnétiques pour la plupart de ces systèmes. De plus, certaines des chaînes ReIV/MnIII et une chaîne ReIV/FeII présentent des comportements magnétiques de type "chaîne aimant" et donc une bistabilité magnétique. / In this thesis, we have synthesised new cyanido bridged heterometallic molecule-based magnetic materials with the tool of simple donor-acceptor coordination chemistry. The 3d metal ion (MnII/III,FeII, NiII, CuII) based molecular precursors acted as acceptor building blocks, whereas the 4d (RuIII)and 5d (ReIV) trans-cyanido type molecular precursors were used as donor moieties.Chapter I contains a theoretical approach with examples of low dimensional magnetic materials:Single Molecule and Single Chain Magnets that illustrate the role of the cyanido ligand to design such magnetic materials. Furthermore, we emphasized the 4d/5d metal based cyanido precursors for their higher magnetic anisotropy over the 3d metal ions. The choice of molecular precursors, their synthesis and characterization were extensively described in chapter II. In this research work, we have obtained many heterometallic molecular complexes and also one dimensional systems. Chapter III, IV and V contain the synthesis, X-ray crystallographic and magnetic characterization of all the newly synthesized complexes. The close crystal packing of the molecules lead to an antiferromagnetic ground state for most of the complexes and this often perturbed the magnetic relaxation phenomena. As expected, we have found metamagnetic phase diagrams for most of these systems. Some of the ReIV/MnIII and a ReIV/FeII one dimensional compounds exhibited Single-Chain magnet like properties and thus magnetic bistability.

Prostate cancer is one of the most common human malignancies and, consequently it is critical to develop appropriate diagnostic and therapeutic tools. Glutamate carboxypeptidase II (GCPII) is currently being considered one of the most important prostate cancer markers due to its tissue- specific expression. Whereas in healthy prostatic tissue the expression levels of GCPII are low, the transformation into the tumor is associated with the substantial increase of GCPII expression, with the highest levels observed in androgen-independent metastatic tumors. GCPII is thus considered a promising marker for early phase as well as advanced metastatic stages of prostate cancer. Current research is focused on the development of highly sensitive and specific reagents that allow detection of small amounts of GCPII, for example in early stages of cancer. Antibody derivatives are promising molecules for this purpose because they have high affinity and specificity and minimum negative side effects. Protein engineering is a prefered approach for preparation of various antibody molecules that differ in size, binding properties, stability, solubility, and production means. Different types of derivatives are being developed for medical needs such as in vitro diagnosis, therapy, and in vivo imagingSmall molecular...